Skip to main content

Table 1 Baseline characteristics of all cases of possible DILI (pDILI)

From: Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK

Characteristic

 

n (%)

pDILI

 

105

Sex

Female

49 (46.7)

 

Male

56 (53.3)

Age (years)

18–24

17 (16.2)

 

25–29

22 (21.0)

 

30–34

10 (9.5)

 

35–39

13 (12.4)

 

40–49

14 (13.3)

 

50–59

12 (11.4)

 

60+

17 (16.2)

Ethnic origin

Indian

55 (52.4)

 

Pakistani

8 (7.6)

 

Nepalese

8 (7.6)

 

Afghan

2 (1.9)

 

Somali

4 (3.8)

 

Romanian

2 (1.9)

 

Black

6 (5.7)

 

White

11 (10.5)

 

Asian (Other)

7 (6.7)

 

Other

2 (1.9)

Site of tuberculosis

  

Pulmonary

 

21 (20)

Extrapulmonary

 

61 (58.1)

Both

 

23 (21.9)

Total culture confirmed

 

62 (59)

Fully sensitive TB

 

56 (53.3)

Isoniazid monoresistant TB

 

3 (2.9)

Multi-drug resistant TB

 

3 (2.9)

HIV positive

 

8/96 (7.6)

HCV positive (detectable RNA)

 

3/98 (3.0)

HBV positive

 

0/101 (0)

Alcohol Excessa

 

9/105 (8.6)

Chronic Liver Diseaseb

 

7/105 (6.7)

No risk factorc

 

78/105 (74.2)

Other risk factors

 

Median (IQR), n

Baseline ALT (IU/L) (normal range 10–50)

24 (17–32), n = 77

Baseline ALP (IU/L) (normal range 30–130)

98 (75–135), n = 77

Baseline BILI (umol/L) (normal range 0–21)

8 (6–12), n = 77

Weight (kg)

 

53.9 (48.0–65.0), n = 74

Rifampicin dose per kg

(if given)

9.98 (9.00–11.1), n = 74

Isoniazid dose per kg

(if given)

5.57 (4.62–6.25), n = 74

Pyrazinamide dose per kg

(if given)

25.8 (22.7–29.8), n = 74

Moxifloxacin dose per kg

(if given)

7.34 (6.15–8.15), n = 36

  1. aAlcohol excess is defined as >21 units per week for men or >14 units per week for women. bCauses of chronic liver disease are as follows: hepatitis C (3), alcoholic liver disease (2), autoimmune hepatitis (1) and 1 drug related, secondary to methotrexate. cAs defined by ATS/BTS